Literature DB >> 24969861

Prevalence, risk factors and disease knowledge of breast cancer in Pakistan.

Hafiz Muhammad Asif1, Sabira Sultana, Naveed Akhtar, Jalil Ur Rehman, Riaz Ur Rehman.   

Abstract

Breast cancer is the most common cancer in females all over the world with approximately one million new cases each year as well as one of second leading causes of death among females. In Pakistan, the most frequently diagnosed cancer among females is also breast cancer, accounting for nearly one in nine female patients. Its incidence in Pakistan is 2.5 times higher than that in neighboring countries like Iran and India. The risk factors associated with breast cancer are age, family history, early menarche, intake of combined estrogen and progestin menopausal hormones, alcohol consumption, physical inactivity, low socioeconomic status and lack of awareness regarding the disease. This mini-review article aims to provide awareness about breast cancer as well as an updated knowledge about the prevalence, risk factors and disease knowledge of breast cancer in Pakistan.

Entities:  

Mesh:

Year:  2014        PMID: 24969861     DOI: 10.7314/apjcp.2014.15.11.4411

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  16 in total

1.  Factors influencing delayed presentation of breast cancer at a tertiary care hospital in Pakistan.

Authors:  Mehreen Baig; Iram Sohail; Humera Naz Altaf; Omar Shahzad Altaf
Journal:  Cancer Rep (Hoboken)       Date:  2018-10-11

2.  FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.

Authors:  Ying Liu; Xiang Ao; Zhaojun Jia; Xiao-Yan Bai; Zhaowei Xu; Gaolei Hu; Xiao Jiang; Min Chen; Huijian Wu
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

3.  Effect of health-belief-model-based training on performance of women in breast self-examination.

Authors:  Fatemeh Nahidi; Mahrokh Dolatian; Nasibeh Roozbeh; Zeynab Asadi; Nezhat Shakeri
Journal:  Electron Physician       Date:  2017-06-25

4.  Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and in-silico expression analysis of CXCL12-CXCR4 associated biological regulatory network.

Authors:  Samra Khalid; Rumeza Hanif
Journal:  PeerJ       Date:  2017-09-15       Impact factor: 2.984

5.  Women's Views on Handling and Managing Their Breast Cancer in Pakistan: A Qualitative Study.

Authors:  Najma Naz; Sabiha Khanum; Grace Teresinha Marcon Dal Sasso; Maria de Lourdes de Souza
Journal:  Diseases       Date:  2016-04-14

6.  Breast Cancer knowledge and perceived barriers to help seeking among pre-clinical and clinical female medical students of King Edward Medical University, Lahore: a cross-sectional study.

Authors:  Saleha Qasim; Hamnah Tayyab; Kainat Zulqadar; Somer Masood; Tahira Bano Qasim; Zainab Zubair
Journal:  BMC Med Educ       Date:  2020-07-14       Impact factor: 2.463

7.  Patient Delay in Breast Cancer Diagnosis in Two Hospitals in Karachi, Pakistan: Preventive and Life-Saving Measures Needed.

Authors:  Uzma Shamsi; Shaista Khan; Iqbal Azam; Shaheryar Usman; Amir Maqbool; Tiffany Gill; Romaina Iqbal; David Callen
Journal:  JCO Glob Oncol       Date:  2020-06

8.  Validity and Reliability of the Turkish Version of the Modified Breast Cancer Worry Scale.

Authors:  Sermin Timur Taşhan; Tuba Uçar; Yeşim Aksoy Derya; Gülçin Nacar; Behice Erci
Journal:  Iran J Public Health       Date:  2018-11       Impact factor: 1.429

9.  Breast Cancer Awareness and Associated Factors Amongst Women in Peshawar, Pakistan: A Cross-Sectional Study.

Authors:  Zia Ullah; Muhammad Naseem Khan; Zia Ud Din; Saima Afaq
Journal:  Breast Cancer (Auckl)       Date:  2021-06-22

10.  Hyperlipidemia and hyper glycaemia in Breast Cancer Patients is related to disease stage.

Authors:  Uzma Raza; Mahay Rookh Asif; Asif Bin Rehman; Aminuddin Sheikh
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.